Navigation Links
Pink OTC Markets Moves Natural Fuels Industries to Top Tier
Date:3/26/2009

MISSOULA, Mont., March 26 /PRNewswire-FirstCall/ -- NATURAL FUELS INDUSTRIES, INC. (Pink Sheets: VGPR) today announced that Pink OTC Markets has raised their rating for the Company to "Fully Compliant", its highest tier for Pink Sheet companies.

Pink OTC Markets categorizes all securities trading over-the-counter into easily identifiable tiers that inform investors whether an issuer has made adequate public information available in a timely manner. Subsequent to NFI's recent filing, Pink OTC Markets raised the Company's rating to "Fully Compliant".

Bill Jacobson, CEO of Natural Fuels Industries stated, "We are happy to have met the requirements for Pink OTC Markets to change their rating. This is one more step in our reorganization plan. It is our intention to keep the filings up to date and our shareholders informed as we move forward with the implementation of our Business Plan."

Natural Fuels Industries manufactures and markets various products including energy efficient pellet fuel made from organic waste bi-products using unique and innovative ideas combined with proven technology. The Company's current expansion includes building manufacturing plants in various international locations that will produce bio-mass products and bio-diesel products for power generation units. It is estimated that in the next five years the bio mass industry will become a $20 billion industry.

Certain statements in this release constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast," "project," "intend," "expect" "should," "would," and similar expressions and all statements, which are not historical facts, are intended
'/>"/>

SOURCE Natural Fuels Industries, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
4. AMERIGROUP Corporation to Present at the CIBC World Markets 18th Annual Healthcare Conference on November 5
5. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
6. Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference
7. AMN Healthcare Services to Present at the CIBC World Markets 18th Annual Healthcare Conference
8. CryoCor to Present at CIBC World Markets 18th Annual Healthcare Conference
9. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Renovis to Present at CIBC World Markets Healthcare Conference
11. Protalix BioTherapeutics to Present at CIBC World Markets 18th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10Brooding fishes take up nutrients from their own children 2First-in-class treatment for acute leukemia 2First-in-class treatment for acute leukemia 3Peregrine Pharmaceuticals Adds Noted Oncologist Dr Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 55686 1Peregrine Pharmaceuticals Adds Noted Oncologist Dr Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 55686 2Peregrine Pharmaceuticals Adds Noted Oncologist Dr Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 55686 3Peregrine Pharmaceuticals Adds Noted Oncologist Dr Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 55686 4Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 1Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 2Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 4BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 1BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 3